Veritas Genetics
Veritas Genetics is a personal genomics startup based in Danvers, Massachusetts. It was co-founded in 2014 by George M. Church, Mirza Cifric, Preston Estep, and Jonathan Zhao. Its flagship product, myGenome, aims to provide consumers with information about their genetic risk for disease and allergic reactions based on whole-genome sequencing results. It initially debuted for $999, the first clinical-grade whole genome sequence and interpretation to break the $1000 price barrier. In the fall of 2018, the company lowered prices to $199 for either the first 1,000 customers to buy one of their kits or for the first two days of the discount. Veritas co-founder and CEO Mirza Cifric said that, by slashing prices dramatically, "We’re sending a clear signal to the medical research community that the $99 genome will be here in three to five years." After this sale ended, the price of myGenome was lowered to $599 in 2019. It was named one of the CNBC Disruptor 50 in 2018 and 2019.
